Wednesday - March 25, 2026
FDA Center for Devices & Radiological Health Issues Warning Letter to IsoTis OrthoBiologics
March 25, 2026
WASHINGTON, March 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to IsoTis OrthoBiologics Inc. from its Center for Devices and Radiological Health:

* * *

Recipient: Peter P. Nalbach, Vice President and General Manager of Spine Operations, IsoTis OrthoBiologics, Inc., 2 Goodyear, Ste A, Irvine, CA 92618, United States, (b)(4)

Issuing Office: Center for Devices and Radiological Health, U . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products